Kenneth D. Bromberg

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 858 citations · Full text

Medicine, Cancer Biology, Oncology +8

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Brian T. Weinert, Takeo Narita, Shankha Satpathy et al. · Cell · 2018 · 541 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +4

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg, Olga Motorna, Leonie A. Cluse et al. · Molecular Cell · 2021 · 170 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A Two-drug Model for Etoposide Action against Human Topoisomerase IIα

Kenneth D. Bromberg, Alex B. Burgin, Neil Osheroff · Journal of Biological Chemistry · 2003 · 143 citations · Full text

Medicine, Molecular Biology, Pharmacology +15

Design Logic of a Cannabinoid Receptor Signaling Network That Triggers Neurite Outgrowth

Kenneth D. Bromberg, Avi Ma’ayan, Susana R. Neves et al. · Science · 2008 · 141 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17